Abstract: The present invention relates novel methods and compositions for blocking transmission of Plasmodium vivax which cause malaria. In particular, Pvs25 and Pvs28 polypeptides, variants, including deglycosylated forms, and fusion proteins thereof, are disclosed which, when administered to a susceptible organism, induce an immune response against a 25 kD and 28 kD protein, respectively, on the surface of Plasmodium vivax zygotes and ookinetes. This immune response in the susceptible organism can block transmission of malaria.
Type:
Application
Filed:
July 2, 2008
Publication date:
November 6, 2008
Applicant:
The Gov. of the USA as represented by the Secretary of the Dep. of Health and Human Services
Inventors:
David C. KASLOW, Takafumi Tsuboi, Motomi Torii
Abstract: This invention relates to methods of screening for compounds capable of inducing apoptosis in certain tumor cells. The invention also relates to compounds identified by such methods. In addition, the invention relates to methods for the in vitro diagnosis of Xeroderma pigmentosum and compounds useful in these methods.
Type:
Application
Filed:
August 4, 2003
Publication date:
June 17, 2004
Applicant:
The Gov. of the USA as represented by the Secretary of the Dep. of Health and Human Services
Inventors:
Curtis C. Harris, Xin Wei Wang, Jan H.J. Hoeijmakers